Jindřich Fínek

Charles University — Czech Republic

Medicine · Health Sciences

24h-index2.0kcitations282works1.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Colorectal Cancer Treatments and Studies(52), Lung Cancer Treatments and Mutations(44), Multiple and Secondary Primary Cancers(39), Cancer Treatment and Pharmacology(30), Gastric Cancer Management and Outcomes(28)

Publications282 total

Risks of haematological malignancies in patients treated for solid tumours associated with the use of pegylated granulocyte colony‑stimulating factors: A single centre study since 2005
Oncology Letters·2025Open Access
Identifying Leukopenia, Renal Dysfunction and Other Factors Limiting Concomitant Chemoradiotherapy in Locally Advanced Cervical Cancer: A Way to Focus on the Importance of Supportive Care and Potentially Improve Treatment Results?
Cureus·2025Open Access
503 Association of long-term treatment outcomes with changes in PET/MRI characteristics in locally advanced cervical cancer patients.
Radiotherapy and Oncology·2025
Association of long-term treatment outcomes with changes in PET/MRI characteristics and the type of early treatment response during concurrent radiochemotherapy in patients with locally advanced cervical cancer
Strahlentherapie und Onkologie·2025· 3 citedOpen Access
Prognostic Role of Prostate-specific Antigen Isoforms and Their Early Kinetics in Patients With Metastatic Castration-resistant Prostate Cancer Receiving New Generation Androgen Receptor Targeted Agents
In Vivo·2025· 2 citedOpen Access
Trends of the use of pegylated granulopoiesis growth factors in clinical practice – single oncology centre experience since 2005
Klinicka onkologie·2024Open Access
Trends of the use of pegylated granulopoiesis growth factors in clinical practice – single oncology centre experience since 2005
Klinicka onkologie·2024Open Access
Giant Cell Temporal Arteritis Followed by Severe Encephalopathy Induced by Immunotherapy in a Patient with Metastatic Renal Cell Carcinoma Achieving Durable Partial Response: A Case Report
Case Reports in Oncology·2024· 1 citedOpen Access
PLAG1-Rearranged Uterine Sarcomas: A Study of 11 Cases Showing a Wide Phenotypical Spectrum Not Limited to Myxoid Leiomyosarcoma-Like Morphology
Modern Pathology·2024· 12 cited
130: Treatment outcomes of MRI-guided adaptive brachytherapy in patients with advanced cervical cancer
Radiotherapy and Oncology·2024
Feasibility of implementation of the early tumor shrinkage as a potential predictive marker to daily clinical practice in patients with RAS wild type metastatic colorectal cancer, treated with cetuximab – a non-interventional observational study
Klinicka onkologie·2024Open Access
Concomitant antihypertensive medication and outcome of patients with metastatic castration‐resistant prostate cancer receiving enzalutamide or abiraterone acetate
Cancer Medicine·2024· 3 citedOpen Access
Enzalutamide or Abiraterone Acetate With Prednisone in the Treatment of Metastatic Castration-resistant Prostate Cancer in Real-life Clinical Practice: A Long-term Single Institution Experience
Anticancer Research·2022· 3 citedOpen Access
Extrahepatic bile duct malignancies
Perspectives in Surgery·2022Open Access
Treatment outcomes of MRI-guided adaptive brachytherapy in patients with locally advanced cervical cancer: institutional experiences
Strahlentherapie und Onkologie·2022· 11 cited
Combination of Circulating Tumour DNA and<sup>18</sup>F-FDG PET/CT for Precision Monitoring of Therapy Response in Patients With Advanced Non-small Cell Lung Cancer: A Prospective Study
Cancer Genomics & Proteomics·2022· 18 citedOpen Access
Molecular testing in endometrial carcinoma – joint recommendation of Czech Oncological Society, Oncogynecological Section of the Czech Gynecological and Obstetrical Society, Society of Radiation Oncology, Biology and Physics, and the Society of Czech Pathologists
Česká gynekologie·2021· 4 cited
Molecular testing in endometrial carcinoma – joint recommendation of Czech Oncological Society, Oncogynecological Section of the Czech Gynecological and Obstetrical Society, Society of Radiation Oncology, Biology and Physics, and the Society of Czech Pathologists
Klinicka onkologie·2021· 2 citedOpen Access
Impact of Concomitant Cardiovascular Medication on Survival of Metastatic Renal Cell Carcinoma Patients Treated with Sunitinib or Pazopanib in the First Line
Targeted Oncology·2021· 17 cited
PD-0814 Prediction of treatment response in patients with advanced cervical cancer using mid-PET/MRI
Radiotherapy and Oncology·2021
page 1 of 15Next →

Frequent Co-authors

Ondřej Topolčan(29), Ondřej Fiala(25), Miloš Pešek(17), L Holubec(15), Lucie Benešová(12), Marek Minárik(12), Tomáš Büchler(10), Zbyněk Bortlíček(10), Radek Kučera(9), Ondřej Šorejs(8), Vladislav Třeška(7), Martin Pešta(5), Bohuslav Melichar(5), Václav Liška(5), Stanislav Kormunda(5), Alexandr Poprach(5), Šárka Svobodová(5), Martin Svatoň(5), Jaroslav Ráček(4), Vít Martin Matějka(4)